DETERMINANTS INFLUENCING TIME IN THERAPEUTIC RANGE AMONG PATIENTS RECEIVING WARFARIN THERAPY: A NARRATIVE REVIEW
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Effective control of anticoagulation therapy is crucial to minimize the risk of thromboembolic events and bleeding complication. For the prevention and treatment of thromboembolic disorders, warfarin is still frequently recommended orally, especially in patients with atrial fibrillation and mechanical heart valve replacement. However, keeping the International Normalized Ratio (INR) within the therapeutic range is crucial to the clinical efficacy of warfarin therapy. Time in Therapeutic Range (TTR), which represents the proportion of time that INR readings stay within the therapeutic range, is a commonly used indicator of anticoagulation quality. A higher risk of bleeding and thromboembolic consequences is linked to suboptimal TTR. TTR can be greatly impacted by a number of factors, including age, medication adherence, dietary practices, the frequency of INR testing, and drug interactions. In addition to highlighting tactics that could enhance anticoagulation control, this narrative review summarizes the body of research on the variables influencing TTR in patients on warfarin medication.
Fields of Study & Subjects
Atrial Fibrillation Management and Outcomes
Venous Thromboembolism Diagnosis and Management
Pharmacogenetics and Drug Metabolism
Publication details
- Journal / source
- INTERNATIONAL JOURNAL OF CURRENT SCIENCE
- Volume
- 16
- Issue
- 1
- Publication date
- 1 January 2026
- Language
- EN